Date post: | 20-Aug-2015 |
Category: |
Health & Medicine |
Upload: | medicres |
View: | 395 times |
Download: | 1 times |
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Practical and statistical aspects of randomization and blinding in clinical trials
Jonas Ranstam PhD
Department of Clinical Sciences
Lund University
Sweden
Outline Why randomize?
- Statistical principles and phenomena
- Historical examples
How can randomization and blinding be achieved in practice?
- Simple randomization
- Block randomization
- Blocking, or stratified randomization
- Cluster randomization
- Dynamic allocation
- Blinding
Statistical issues with randomization
- Common misunderstandings
- How to do it
Suggestions
- Regulatory guidelines
- Reporting guidelines
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Why not test a drug on a single patient?
Problem
A treatment effect estimate from a single patient does not provide any
information on estimation uncertainty.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Why not test a drug on a single patient?
Problem
A treatment effect estimate from a single patient does not provide any
information on estimation uncertainty.
Solution
Use a random sample from the infinite population of current and
future patients, and calculate the uncertainty of the findings using
statistical inference.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Why not use one group of patients?
Problem: Temporal variability within patients
The response to a treatment usually varies over time. A consequence
is the regression-to-the-mean effect, which often is misunderstood as
a “placebo effect”.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
----------------------------------------------------------------------- Variable Obs Mean SD Min Max Change (95% Ci) p-value ----------------------------------------------------------------------- All observations Baseline 100 150 25 92 206 Follow up 100 150 25 91 209 0 (-7, 7) ≈1
Baseline 150+ mmHG Baseline 49 171 14 150 206 Follow up 49 150 25 91 209 20 (11, 28) <0.001 -----------------------------------------------------------------------
Regression-to-the-mean
Simulated blood pressure data using Stata
n: 100
Distribution: Gaussian
Baseline: mean 150 (SD 25) mmHg
Follow up: mean 150 (SD 25) mmHg
Correlation baseline-follow up: 0
Treatment effect: None
Establishing a control group
Problem: Temporal variability within patients
Solution: Use a control group
An untreated group from the same source of subjects and with
identical inclusion/exclusion criteria will have the same regression-to-
the-mean.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Establishing a control group
Problem: Confounded treatment effects
Treatment response may depend on known and unknown factors (like
age, gender, co-morbidity, etc.), which may be unevenly distributed
between the two groups.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Establishing a control group
Amberson JB Jr, McMahon BT, Pinner M. A clinical trial of sanocrysin in pulmonary tuberculosis.
Am Rev Tuberc 1931;24:401–435.
The 24 (tuberculosis) patients were then divided into
two approximately comparable groups of 12 each.
The cases were individually matched, one with another,
in making this division. ... Then by a flip of the coin, one
group became identified as group I (treated group) and
the other as group II (control).
Establishing a control group
Problem: Confounded treatment effects
Solution: Alternation
This methods was used before 1948.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Medical Research Council. Clinical trial of patulin in the common cold. Lancet 1944; ii: 373-5.
The first properly controlled multicentre trial
Patulin and the common cold
Patulin (Penicillium patulum) was considered for cancer treatment during
1943. The director of the Imperial Cancer Research Fund's laboratories,
WE Gye, had a severe cold and sprayed his nasal passages with patulin.
His blocked nose cleared within an hour and the following morning his
cold had gone. A controlled trial was initiated.
Clarke M. The 1944 patulin trial of the British Medical Research Council. J R Soc Med. 2006;99: 478–480.
Patulin and the common cold
Eligible patients, suffering from common cold, were alternately (every other) allocated to patulin or a placebo group.
------------------------------------------------
Group Patient number
------------------------------------------------
Patulin: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19...
Placebo: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20...
------------------------------------------------
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Patulin and the common cold
Conclusion
“No evidence was found that patulin is effective in the treatment of the
common cold”
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Why is alternation not used today?
Problem: Allocation outcome is predictable
An investigator can interfere with the allocation of patients by selecting
patients to participate in the trial, creating selection bias.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Why is alternation not used today?
Problem: Allocation outcome is predictable
Solution: Randomize and conceal the outcome
Keep the allocation outcome concealed until the patient is entered into
the trial.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Theobald GW. Effect of calcium and vitamin A and D on incidence of pregnancy toxaemia.
Lancet 1937;2:1397-1399.
The first randomized trial
Reporting and observer bias
Problem: Subjectivity
Randomized groups are comparable at baseline, but measurements
made during the trial can be biased by patients' and or investigators'
subjective belief.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Reporting and observer bias
Problem: Subjectivity
Solution: Blinding
Keep the allocation outcome concealed, not only at randomization but
during the entire trial: “blinding”.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council
investigation. BMJ 1948;2:769-782.
The first randomized and blinded trial
How can randomization and blinding be achieved in
practice?
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Alternation
Two groups, TRT and PBO, 20 patients
TRT PBO TRT PBO TRT PBO TRT PBO TRT PBO
TRT PBO TRT PBO TRT PBO TRT PBO TRT PBO
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Simple randomization
Two groups A and B, 20 patients
A B A B A A B A A A A B A B B B B B B A
Whether A or B stands for placebo is kept secret, at least in double
blinded trials.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Stata program
set obs 20
gen grp="A"
replace grp="B" if _n>10
gen rnd=uniform()
sort rnd
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Concealment of outcome
Opaque envelopes, telephone service, Internet service
Problem
It may be necessary to break the code (unblind) in case of a medical
emergency. This must be clearly document, and the code should be
kept unbroken for other patients.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Simple randomization
Two groups, A and B, 20 patients
A B A B A A B A A A A B A B B B B B B A
Problem: may create unnecessary imbalance
Especially in the case of performing an interim analysis.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Block randomization
Two groups A and B, 20 patients, block size 4
[A B A B] [A A B B] [A B A B] [A B B A] [B A B A]
Problem
Does not balance known prognostic factors.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Stratified (block) randomization
Two groups A and B, 20 patients, block size 4,
stratified (blocking) on gender
Males: [A B A B] [A A B B] [A B A B] [A B B A]
Females: [B A A B] [B A B A] [B B A A] [A B B A]
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Cluster randomization
A cluster randomized trial is a trial in which individuals are randomized
in groups.
Examples
General practices, hospitals, families, school classrooms, football
teams.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Cluster randomization
An antihistamine and seasickness trial was performed using two troop
transport ships in the north Atlantic during 1916. On one of the ships
the troops received treatment. The troops on other ship were controls.
Randomization
Dynamic allocation
The number of previously enrolled patients having the same
prognostic factor as the new patient is counted.
The new patient is then allocated to the treatment arm for which the
sum of the previously enrolled patient prognostic factor counts is
smallest.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Dynamic allocation
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Dynamic allocation
Next patient is a man aged 23
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Dynamic allocation
Next patient is a man aged 23
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Randomization
Dynamic allocation
Several methods exist (e.g. Pocock & Simon, Perry, Heritier, etc.)
The allocation must include a chance element. It must not be
deterministic.
Statistical analyses must be conditional on all factors included in the
algorithm.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Open label
Sometimes the circumstances of a trial make it impossible to
conceal the identity of the treatment patients are receiving.
Blinding is particularly difficult in surgical trials, although
standardized wound dressings, sham operations, or independent
outcome evaluation may be useful.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Single blind
The patient does not know if treatment or placebo has been
administered.
Double blind
Neither the patient, nor the physician, knows if treatment or placebo
has been administered.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Double blind is better then single blind
More complex logistics.
Not always possible to achieve.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Triple blind
When the code list has been lost.
This is not a good thing.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Identical shape, weight and color
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Blinding
Identical shape, weight and color
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Statistics is often misunderstood
The null hypotheses tested in hypothesis tests are about the
parameters of a hypothetical population, not about the observed
sample.
The p-value, SEM, and confidence interval describe the uncertainty
in a generalization.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Statistics is often misunderstood
Randomization has consequences for the statistical analysis.
We will discuss some common misconceptions about the
consequences of randomization.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
The aim of randomization is balance
Randomization protects against systematic imbalance (selection bias)
but not against random.
Randomization makes sure that the null hypothesis is true, and that
assumptions underlying statistical methods (like homogeneous
variance) are fulfilled.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Blocking is not necessary
Yes it is, blocking for known predictors reduces estimation errors.
The design and analysis of experiments should take into account all
of the major sources of variability that are expected to influence the
responses.
“Block what you can, randomize what you cannot block”.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Only compliant patients should be analysed
Excluding patients from the analysis is a potential risk for selection
bias.
The ITT population consists of all randomized subjects, without
exclusion because of non-compliance, protocol deviations,
withdrawal, or anything else that happens after randomization.
The prognostic balance generated by the randomization is
maintained in the ITT population.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Only compliant patients should be analysed
The ITT approach is often combined with an analysis of the per-
protocol (PP) population. This is defined as the subset of the ITT
population that completed the study without major protocol
violations.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception: It can be tested if the
randomization has been successful
Many published trial reports include a Table 1. with hypothesis tests of
imbalance at baseline, after randomization.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS. A Randomized Trial of Treatment for Acute Anterior
Cruciate Ligament Tears. N Engl J Med 2010; 363:331-342.
It can be tested if the randomization has been successful
Misconception:
It can be tested if the randomization has been
successful
With randomization we know the null hypothesis is true.
The risk of a false positive test outcome will depend on the specified
false positive rate (the significance level).
With 5% significance level and 20 tested null hypothesis at least one
false positive test should be expected.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
It can be tested if the randomization has been
successful
If imbalance is detected it cannot be adjusted away using
epidemiological methods.
With flawed randomization the results of the trial will also be flawed.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
It can be tested if the randomization has been
successful
Imbalance at baseline is a property of the sample, not the population.
This common misconception indicates confusion of sample and
population.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Blocking factors can be ignored in the
analysis
Factors used for stratifying the randomization are not always
included in the analysis.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Blocking factors can be ignored in the
analysis
This leads to an incorrect variance estimate.
Include randomization stratification factors as covariates in the
statistical analysis.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Cluster randomized trials can be analyzed as
any other trial
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Cluster randomization
An antihistamine and seasickness trial was performed using two troop
transport ships in the north Atlantic during 1916. On one of the ships
the troops received treatment. The troops on other ship were controls.
Misconception:
Cluster randomized trials can be analyzed as
any other trial
Having a unit of analysis other than the unit of randomization can
create dependency problems.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
Misconception:
Cluster randomized trials can be analyzed as
any other trial
Randomizing clusters and analyzing subjects leads to an
underestimation of variance, the extent of which is known as the
variance inflation factor, IF.
IF = 1 + (m − 1) ρ
ρ = intraclass correlation and
m = average cluster size
Misconception:
Cluster randomized trials can be analyzed as
any other trial
A standard patient number calculation leads to an underpowered
trial.
A standard statistical analysis exaggerates the statistical
significance.
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
ICH-E9 Statistical Principles
http://www.ema.europa.eu/pdfs/human/ich/036396en.pdf
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey
CONSORT Statement
http://www.consort-statement.org/
MedicReS Good Clinical Research CME June 7-8 2013 | Istanbul Turkey